Preeclampsia and fetal growth retardation: Is there an association with antiphospholipid antibodies?

Hypertension in Pregnancy

Volumn 17, Issue 1, 1998, Pages 81-92

  Schjetlein, Rune ^a   Haugen, Guttorm ^b   Moe, Narve ^b   Husby, Henrik ^a   Wisløff, Finn ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antiphospholipid antibodies; Fetal growth retardation; HELLP syndrome; Preeclampsia

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREECLAMPSIA; PROSPECTIVE STUDY;

EID: 0031920235     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959809072240     Document Type: Article

References (26)

1. Triplett DA. Assays for the detection of antiphospholipid antibodies. Lupus 1994; 3:281-7.
2. Triplett DA. Clinical significance of antiphospholipid antibodies. Thromb Hemost 1988;10:1-12.
3. Liu HW, Wong KL, Lin CK, Wong WS, Tse PWT, Chan GTC. The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant. Br J Haematol 1989;72:229-34.
4. Schjetlein R, Wisløff F. An evaluation of two commercial test procedures for the detection of lupus anticoagulant. Am J Clin Pathol 1995;103:108-11.
5. Triplett DA. Laboratory diagnosis of lupus anticoagulants. Sem Thromb Hemost 1990;16:182-92.
6. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541-5.
7. Rafla N, Farquharson R. Lupus anticoagulant in pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 1991;42:167-70.
8. Sletnes KE, Wisløff F, Moe N, Dale PO. Antiphospholipid antibodies in preeclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynaecol Scand 1991;71:112-7.
9. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86:555-9.
10. Carreras LO, Vermylen J, Spitz B, Van Assche A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intra-uterine growth retardation and intra-uterine death. Br J Obstet Gynaecol 1981;88:890-4.
11. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829-34.
12. Out HJ, Kooijman CD, Bruinse HW, Derksen RHWM. Histopathological findings in placentae from patients with intra-uterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynaecol Reprod Biol 1991;41:179-86.
13. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161:369-73.
14. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal - perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-9.
15. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
16. Poldre PA. Haptoglobin helps diagnose the HELLP syndrome. Am J Obstet Gynecol 1987;157:1267.
17. Bjerkedal T, Bakketeig L, Lehmann EH. Percentiles of birth weights of single, live births at different gestation periods. Acta Pædiat Scand 1973;62:449-57.
18. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
19. Sletnes KE, Keirung G, Wisløff F. Quantitation of anticephalin antibodies in a computer-assisted enzyme-linked immunosorbent assay (ELISA): relation to lupus anticoagulant. Thromb Res 1990;57:235-46.
20. Gilman-Sachs A, Lubinski J, Beer AE, Brend S, Beaman KD. Patterns of antiphospholipid antibody specificities. J Clin Lab Immunol 1991;35:83-8.
21. Schjetlein R, Sletnes KE, Wisløff F. A quantitative, semi-automated computerassisted test for lupus anticoagulant. Thromb Res 1993;69:239-50.
22. Moodley J, Bhoola V, Duursma J, Pudifin D, Byrne S, Kenoyer DG. The association of antiphospholipid antibodies with early-onset of severe pre-eclampsia before 30 weeks' gestation. S Afr Med J 1995;85:105-7.
23. Schei B, Østensen M, Moen T, Jacobsen G, Bakketeig LS. Can maternal antiphospholipid antibodies predict the birth of a small-for-gestational age child? Acta Obstet Gynaecol Scand 1995;74:425-8.
24. Triplett DA. Screening for the lupus anticoagulant. Res Clin Lab 1989;19:379-89.
25. Ornstein MH, Rand JH. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy, a report of 2 cases. J Rheumatol 1995; 21:1360-4.
26. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe complication of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-67.